Is Visus Therapeutics, Inc. FDA approved?

Visus Therapeutics, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does Visus Therapeutics, Inc. make?

1 product is listed under Visus Therapeutics, Inc. in the openFDA NDC Directory, most often as solution/ drops. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Visus Therapeutics, Inc.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 1
Live patents: 2
Exclusivities: 1
Countries: 0

Exclusivity

Patents and exclusivities

Patent	Product	Covers	Expiry
8455494	YUVEZZIbrimonidine tartrate; carbachol	use	May 2030
12268662	YUVEZZIbrimonidine tartrate; carbachol	product	Nov 2042

Product	Exclusivity	Until
YUVEZZIBRIMONIDINE TARTRATE; CARBACHOL	NP New product	Jan 2029

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
YUVEZZI	carbachol and brimonidine tartrate	solution/ drops, ophthalmic	84892-275NDA

Enquiry

Common questions

Is Visus Therapeutics, Inc. FDA approved?: Visus Therapeutics, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Visus Therapeutics, Inc. make?: 1 product is listed under Visus Therapeutics, Inc. in the openFDA NDC Directory, most often as solution/ drops. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.